Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development

OBJECTIVE: Despite recommendations by professional organizations that all pregnant women receive inactivated influenza vaccine, safety concerns remain a barrier. Our objective was to assess the effect of trivalent influenza vaccines (IIV3) during pregnancy on parent report 6-month infant development...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Autores principales: Avalos, Lyndsay A., Ferber, Jeannette, Zerbo, Ousseny, Naleway, Allison L., Bulkley, Joanna, Thompson, Mark, Cragan, Janet, Williams, Jennifer, Odouli, Roxana, Kauffman, Tia L., Ball, Sarah, Shifflett, Pat, Li, De-Kun
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7309563/
https://ncbi.nlm.nih.gov/pubmed/32033850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.01.059
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares